BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Rating)'s stock price hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $2.83 and last traded at $2.72, with a volume of 3863 shares trading hands. The stock had previously closed at $2.75.

BioRestorative Therapies Stock Down 1.1 %

The firm has a market cap of $4.46 billion, a price-to-earnings ratio of -6.56 and a beta of 102.36. The company's 50-day moving average price is $3.03 and its 200-day moving average price is $3.13.

BioRestorative Therapies Company Profile

(Get Rating)

BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company's two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.

Recommended Stories

• Get a free copy of the StockNews.com research report on BioRestorative Therapies (BRTXQ)
• Can Investors Cash In On PayPal?
• These 3 Tech Stocks Are in for a Happier New Year
• Tyson Foods: Growth and Momentum at a Reasonable Price
• Can Duke Energy Stock Continue Powering Higher?
• Ready for a Recession? Here's One Defensive Stock You Can't Miss

Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.